Clinical Affairs

The Clinical Affairs team at Richmond Pharmacology focuses on designing and executing innovative clinical studies that drive the development of new therapies. They ensure adherence to regulatory standards while overseeing early-phase trials, including First-In-Human and cardiac safety studies. This multidisciplinary group collaborates closely in protocol development, recruitment strategies, and overall clinical oversight to ensure the successful delivery of safe and impactful treatments to patients. Their work embodies Richmond’s commitment to elevating patient care and transforming healthcare outcomes.